ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc (CRNX)

48.23
2.86
(6.30%)
Closed July 09 4:00PM
48.20
-0.03
(-0.06%)
After Hours: 7:23PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
48.20
Bid
44.50
Ask
48.23
Volume
724,030
45.34 Day's Range 48.28
15.76 52 Week Range 53.70
Market Cap
Previous Close
45.37
Open
45.79
Last Trade Time
Financial Volume
$ 34,276,327
VWAP
47.341
Average Volume (3m)
916,766
Shares Outstanding
78,859,510
Dividend Yield
-
PE Ratio
-17.74
Earnings Per Share (EPS)
-2.72
Revenue
4.01M
Net Profit
-214.53M

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Crinetics Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRNX. The last closing price for Crinetics Pharmaceuticals was $45.37. Over the last year, Crinetics Pharmaceuticals shares have traded in a share price range of $ 15.76 to $ 53.70.

Crinetics Pharmaceuticals currently has 78,859,510 shares outstanding. The market capitalization of Crinetics Pharmaceuticals is $3.58 billion. Crinetics Pharmaceuticals has a price to earnings ratio (PE ratio) of -17.74.

CRNX Latest News

EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner

SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) -- Ernst & Young LLP (EY US) today announced that Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, was named an...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
12.114.5779995660746.0948.2843.7166039944.96886293CS
43.37.3496659242844.948.2841.01109308845.0409718CS
124.8811.265004616843.3253.741.0191676646.41603196CS
2612.2434.037819799835.9653.735.2485598943.93319262CS
5228.45144.05063291119.7553.715.76100340734.63840417CS
15627.34131.06423777620.8653.715.2354738529.0284889CS
26024.0599.585921325124.1553.710.6337592027.35940026CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
ZAPPZapp Electric Vehicles Group Ltd
$ 17.9001
(93.72%)
45.5M
PEGYPineapple Energy Inc
$ 2.30
(91.67%)
77.57M
ATNF180 Life Sciences Corporation
$ 2.9017
(79.12%)
31.21M
QUREuniQure NV
$ 6.65
(75.93%)
51.49M
NVOSNovo Integrated Sciences Inc
$ 0.4874
(-35.44%)
3.12M
FAASDigiAsia Corporation
$ 3.65
(-34.17%)
49.17k
INDVIndivior PLC
$ 10.18
(-33.64%)
2.95M
CLEUChina Liberal Education Holdings Ltd
$ 0.3905
(-31.59%)
9.24M
HUBCWHub Cyber Security Ltd
$ 0.0165
(-31.25%)
1.9k
NVDANVIDIA Corporation
$ 131.38
(2.48%)
287.03M
MAXNMaxeon Solar Technologies Ltd
$ 0.2451
(-9.22%)
233.65M
TSLATesla Inc
$ 262.33
(3.71%)
160.74M
SNGXSoligenix Inc
$ 7.42
(271.00%)
134.15M
INTCIntel Corporation
$ 34.59
(1.77%)
97.8M

Your Recent History

Delayed Upgrade Clock